BELLUS Health Inc. - Common Shares (NQ:BLU)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Jun 28, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BELLUS Health Inc. - Common Shares

< Previous 1 2 3 4 Next >

From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs ↗

July 07, 2023

Goldman Sachs compiled research suggesting the global pharmaceutical sector has approximately $700 billion available for M&A and investments. This significant financial reserve will be crucial as...

Via Benzinga

BELLUS Health Inc. Announces Voting Results from Special Meeting of Shareholders

June 16, 2023

From BELLUS Health Inc.

Via Business Wire

The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree ↗

June 02, 2023

Big Pharma is facing a patent cliff that could siphon off billions in revenue.

Via Investor's Business Daily

BELLUS Health: Q1 Earnings Insights ↗

May 12, 2023

Via Benzinga

GSK Stock: A Value Trap or a Hidden Gem? ↗

April 27, 2023

GSK, formerly known as GlaxoSmithKline, is struggling after a complicated earnings season. Here's why GSK stock is still a buy.

Via InvestorPlace

BELLUS Health Inc. Calls Special Shareholders’ Meeting in Connection with GSK Acquisition

May 16, 2023

From BELLUS Health Inc.

Via Business Wire

BELLUS Health Reports First Quarter 2023 Financial Results and Business Highlights

May 12, 2023

From BELLUS Health Inc.

Via Business Wire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ruth’s Inc. (Nasdaq – RUTH), Magenta Therapeutics, Inc. (Nasdaq – MGTA), BELLUS Health Inc (Nasdaq – BLU), Prometheus Biosciences, Inc. (Nasdaq – RXDX)

May 03, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

Where BELLUS Health Stands With Analysts ↗

April 19, 2023

Via Benzinga

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. (Nasdaq – SPPI), BELLUS Health Inc (Nasdaq – BLU), Prometheus Biosciences, Inc. (Nasdaq – RXDX), Univar Solutions Inc. (NYSE - UNVR)

May 01, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

BELLUS Health Announces Meeting Updates

April 26, 2023

From BELLUS Health Inc.

Via Business Wire

BELLUS Health Inc. (NASDAQ: BLU) Leading the Way in Tuesday Trading Based on Percentage Gain

April 18, 2023

Via Investor Brand Network

3 Biotechs That Might Get Bought Out in 2023 ↗

April 26, 2023

Biotech is expected to be a hotbed of mergers and acquisitions this year.

Via The Motley Fool

Was This Acquisition a Savvy Play by This Big Pharma Stock? ↗

April 26, 2023

The British drugmaker picked up a potential blockbuster drug in its deal for Bellus Health.

Via The Motley Fool

April 25, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

Second Quarter Outlook For Biotech Stocks ↗

April 25, 2023

Biotech stocks have been consolidating recently but may be ready to rally higher due to factors such as a declining 10-year yield and growing M&A activity.

Via Talk Markets

Why This Nasdaq Stock Caught Fire This Week ↗

April 20, 2023

A wave of bargain buying benefited the gene therapy company's shares this week.

Via The Motley Fool

Why Shares of Bellus Health Skyrocketed This Week ↗

April 20, 2023

The company has received a buyout offer from GSK.

Via The Motley Fool

Dow Edges Higher; Goldman Sachs Posts Upbeat Earnings ↗

April 18, 2023

U.S. stocks traded mixed toward the end of trading, with the Dow Jones turning higher on Tuesday. The Dow traded up 0.04% to 34,000.96 while the NASDAQ fell 0.13% to 12,141.79. The S&P 500, also rose,...

Via Benzinga

GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health

April 18, 2023

From BELLUS Health Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For April 19, 2023 ↗

April 19, 2023

Via Benzinga

Dow Dips Over 100 Points; Bank of America Earnings Beat Estimates ↗

April 18, 2023

U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 100 points on Tuesday. The Dow traded down 0.42% to 33,842.93 while the NASDAQ fell 0.10% to 12,146.16. The S&P 500,...

Via Benzinga

Why BELLUS Health Stock Is Rocketing Higher Today ↗

April 18, 2023

A $2 billion buyout agreement with GSK is lighting a fire under the biotech's stock today.

Via The Motley Fool

Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

April 18, 2023

Gainers Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) shares jumped 122% to $1.07 after the company announced the signing of a $60 million strategic investment with two institutional...

Via Benzinga

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: BELLUS Health Inc (Nasdaq – BLU), Prometheus Biosciences, Inc. (Nasdaq – RXDX), Univar Solutions Inc. (NYSE - UNVR)

April 18, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2023 ↗

April 18, 2023

Via Benzinga

US Stocks Mixed; Housing Starts Edge Lower In March ↗

April 18, 2023

U.S. stocks traded mixed this morning, with the Nasdaq Composite dropping over 50 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.12% to 33,945.01 while the NASDAQ rose...

Via Benzinga

Bellus Health Soars 98% As GSK Joins Buyout Bonanza With $2 Billion Deal ↗

April 18, 2023

Shares of its takeover candidate nearly doubled on the news.

Via Investor's Business Daily

Elon Musk Says US Intel Agencies Had Access To Twitter DMs, Alibaba's Ant IPO Might Actually See Light, Airbus Pushes Some 2024 Deliveries: Today's Top Stories ↗

April 18, 2023

Benzinga Elon Musk Drops Bombshell: US Intel Agencies Were Reading Your Twitter DMs

Via Benzinga

Why Is Gamida Cell (GMDA) Stock Up 48% Today? ↗

April 18, 2023

Gamida Cell (GMDA) stock is taking off on Tuesday after getting an update from the FDA concerning cell therapy Omisirge.

Via InvestorPlace

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.